As if things weren't bad enough over many years, that 10-Q

New Post Public Reply Private Reply Replies (1) Message Board
kidmarco DV303 #1559
As if things weren't bad enough over many years, that 10-Q reads like a nightmare. If we didn't think we were screwed before, it just gets worse and worse. There is no one with any sort of a financial background that would even remotely think that this could come back from the dead.
Sorry to be so sour, but those financials are nothing but bad, bad, bad. The profits would have to be so rich to make this work that, if it was hard to believe before, it's even more so now.
Do the math. If George doesn't reign his percentage ownership of shares to bolster the chances of stock holders at large to profit, we're screwed in my opinion. It appears it's gone form worse to worst.
Just my opinion, but I've never felt this low about it. Even if production got going, the profits would have to be astronomical to bring even a meager stock price.
Again, sorry, and I ask for other opinions with some numbers, not just gut opinions to make me think otherwise, but I have a sinking feeling in my gut.
I understand all of the beliefs that George won't give up and it's a great technology and so on, but what would it take for you and I to prosper ? Again, give me some math because I just don't see it.

Coates International (COTE) Stock Research Links

COTE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nvidia's Major $500 Million Investment in Wayve for AI Expansion

Updated Category News Views 206

Nvidia Invests $500 Million in Wayve Nvidia, known for its advanced AI technologies, is in discussions to invest a substantial $500 million into the U.K.-based autonomous driving startup Wayve. This move marks a significant step for Nvidia as it seeks to deepen its involvement in the rapidly evolving artificial intelligence sector. Strategic Importance of the Investment...

Continue Reading
Vortex Companies Enhances Leadership with Key Promotions

Updated Category News Views 164

Elevating Leadership at Vortex Companies Vortex Companies, known for its rapid growth in the trenchless infrastructure rehabilitation sector, has recently made significant leadership changes with the promotions of Jonathan Thomas and Connor Mathis. Thomas steps into the role of Senior Regional Vice President for the Coastal Region, while Mathis ascends to Regional Vice...

Continue Reading
Scilex Holding Company Receives FDA Acknowledgment for ELYXYB

Updated Category News Views 118

Scilex Holding Company’s FDA Milestone with ELYXYB Scilex Holding Company, based in Palo Alto, California, has gained significant recognition with the U.S. FDA's acknowledgment of their Supplemental New Drug Application (SNDA) for ELYXYB. This marks a substantial step forward for the company, which is dedicated to creating and advancing non-opioid pain management...

Continue Reading
Bio-Techne Expands AI-Driven Protein Portfolio

Updated Category News Views 8

Advanced Proteins in the Spotlight Bio-Techne’s latest move is creating some serious buzz in the life sciences scene. They're not just talking the talk but walking the walk by expanding their R&D Systems AI-Engineered Designer Protein portfolio. What's the big news? They've engineered heat-stable and hyperactive proteins that promise to shake up fibroblast growth factor...

Continue Reading
PolyPid's D-PLEX100 Trial Results Revolutionize Infection Prevention

Updated Category News Views 146

Groundbreaking Advances in Surgical Infection Prevention PolyPid Ltd. has made headlines recently, unveiling remarkable topline results from their pivotal SHIELD II Phase 3 trial. This innovative study showcased D-PLEX100, a major breakthrough in preventing surgical site infections (SSIs), showing statistically significant reductions in both primary and secondary...

Continue Reading